Back

FET Open funding to develop drugs against viruses such as HIV, dengue or zika in the brain

FET Open funding to develop drugs against viruses such as HIV, dengue or zika in the brain

The NOVIRUSES2BRAIN project has obtained FET Open funding to develop new drugs that can translocate the blood-brain barrier and fight again viruses. David Andreu’s team at the
UPF takes part in the project. 

 

25.10.2018

This week, the NOVIRUSES2BRAIN project received an FET Open grant of 4.2 million euros from the European Innovation Council (EIC), within the framework of Horizon 2020. The consortium that will carry out the project is made up of researchers from the Institute of Molecular Medicine João Lobo Antunes in Portugal (iMM), the University of Lisbon; Pompeu Fabra University and the German company Synovo GmbH. The project aims to develop drugs that can simultaneously fight against the virus borne by the Aedes mosquito, such as measles, HIV, dengue or zika.

“Viruses that infect the brain and other parts of the central nervous system are a major global threat. In this project we want to find effective drugs that can translocate the blood-brain and the blood-placental barriers, as many viruses are able to overcome these barriers, but existing drugs do not succeed”, explains Miguel Castanho, researcher of the iMM and coordinator of the project.  

Co-infections with Aedes mosquito-borne viruses are likely, because several viral species can co-exist in the same vector. “Moreover, additional co-infections with other viruses such as HIV or measles are also possible, all of them able to accumulate in the brain”, explains David Andreu, head of the Proteomics and Protein Chemistry Research Group at UPF. “This is why we want to develop a drug able to target a very large spectrum of viral species, mainly for Aedes-borne viruses, for which there are no drugs available”, he adds. David Andreu’s team at the Department of Experimental and Health Sciences (DCEXS) at UPF, is in charge of the design, synthetic production at pre-clinical level, and the structural analysis of the candidate drugs, which in a single molecular platform combine a peptide with proven ability to cross the BBB, and several structures with a broad antiviral spectrum.

FET Open, support for new ideas

Future and Emerging Technologies (FET OPEN) funding supports 38 innovative projects to develop new ideas towards radically new future technologies. This European Innovation Council (EIC) pilot offers grants to promote collaborative, inter-disciplinary research and innovation on future and emerging technologies. In its first round of funding, FET Open received 375 proposals and granted funding to 236 beneficiaries in 23 countries across Europe.

List of the beneficiaries.

Per a més informació

Notícia publicada per:

Unitat de Comunicació i Projecció Institucionals

93 542 21 00

[email protected]

Para más información

Noticia publicada por:

Unidad de Comunicación y Proyección Institucionales

93 542 21 00

[email protected]

For more information

News published by:

Institutional Communication and Promotion Unit

93 542 21 00

[email protected]